N. P. Polyzos

923 total citations · 1 hit paper
20 papers, 641 citations indexed

About

N. P. Polyzos is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, N. P. Polyzos has authored 20 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 10 papers in Reproductive Medicine and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in N. P. Polyzos's work include Reproductive Biology and Fertility (11 papers), Ovarian function and disorders (8 papers) and Assisted Reproductive Technology and Twin Pregnancy (8 papers). N. P. Polyzos is often cited by papers focused on Reproductive Biology and Fertility (11 papers), Ovarian function and disorders (8 papers) and Assisted Reproductive Technology and Twin Pregnancy (8 papers). N. P. Polyzos collaborates with scholars based in Belgium, Spain and Greece. N. P. Polyzos's co-authors include Christophe Blockeel, Paul Devroey, Herman Tournaye, L. Van Landuyt, Dominic Stoop, Michel De Vos, Anne Van de Vijver, M. Camus, Basil C. Tarlatzis and Evangelos Papanikolaou and has published in prestigious journals such as Journal of Clinical Oncology, Human Reproduction and Fertility and Sterility.

In The Last Decade

N. P. Polyzos

16 papers receiving 610 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An OHSS-Free Clinic by segmentation of IVF treatment

2011 347 citations Paul Devroey, N. P. Polyzos et al. Human Reproduction profile →

Peers

Countries citing papers authored by N. P. Polyzos

Since Specialization

Citations

This map shows the geographic impact of N. P. Polyzos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. P. Polyzos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. P. Polyzos more than expected).

Fields of papers citing papers by N. P. Polyzos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. P. Polyzos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. P. Polyzos. The network helps show where N. P. Polyzos may publish in the future.

Co-authorship network of co-authors of N. P. Polyzos

This figure shows the co-authorship network connecting the top 25 collaborators of N. P. Polyzos. A scholar is included among the top collaborators of N. P. Polyzos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. P. Polyzos. N. P. Polyzos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can artificial intelligence models provide reliable medical counselling to fertility patients? 2025 ·Reproductive BioMedicine Online ·(unknown), Ariel Weissman, Hadas Ganer Herman, Avi Tsafrir, (unknown), Eran Weiner, Raoul Orvieto, N. P. Polyzos, Michael H. Dahan, Alex Polyakov, Robert Fischer, Sandro C. Esteves, Barış Ata, Jason M. Franasiak, Yossi Mizrachi	0
2	The role of alpha-Klotho protein in male and female reproduction. A systematic review 2024 ·(unknown), (unknown), (unknown), Thomas Fréour, N. P. Polyzos, Francisca Martínez	2
3	Mitigating adverse pregnancy and neonatal outcomes through expanded carrier screening in an oocyte donation programme 2024 ·Reproductive BioMedicine Online ·(unknown), Elísabet Clua, (unknown), (unknown), Thomas Fréour, N. P. Polyzos	0
4	Influence of trophectoderm biopsy for preimplantation genetic testing in the serum level of first trimester biomarkers 2024 ·Reproductive BioMedicine Online ·Pilar Prats, (unknown), (unknown), Ignacio Rodríguez, Bernat Serra, M Parriego, Valeria Donno, N. P. Polyzos	0
5	P–615 The effect of late-follicular phase progesterone rise on embryo ploidy, embryo quality and cumulative live birth rates following a freeze-only strategy 2021 ·Human Reproduction ·(unknown), Samuel Santos‐Ribeiro, (unknown), Sérgio Reis Soares, Juan A. García-Velasco, Nicolás Garrido, N. P. Polyzos	1
6	What is the optimal duration of progesterone administration before transferring a vitrified-warmed cleavage stage embryo? A randomized controlled trial 2016 ·Human Reproduction ·Anne Van de Vijver, N. P. Polyzos, L. Van Landuyt, Shari Mackens, Dominic Stoop, M. Camus, Michel De Vos, Herman Tournaye, Christophe Blockeel	48
7	Estimating life expectancy of the population in Cyprus with the use of life tables. 2016 ·PubMed ·(unknown), Evangelia Nena, (unknown), Athanasios Zissimopoulos, N. P. Polyzos, (unknown), Theodore C. Constantinidis	1
8	A prospective randomized controlled trial investigating the effect of artificial shrinkage (collapse) on the implantation potential of vitrified blastocysts 2015 ·Human Reproduction ·L. Van Landuyt, N. P. Polyzos, N De Munck, Christophe Blockeel, H. Van de Velde, Greta Verheyen	44
9	Cryopreserved embryo transfer in an artificial cycle: is GnRH agonist down-regulation necessary? 2014 ·Reproductive BioMedicine Online ·Anne Van de Vijver, N. P. Polyzos, L. Van Landuyt, Michel De Vos, M. Camus, Dominic Stoop, Herman Tournaye, Christophe Blockeel	34
10	Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to Greece. 2014 ·PubMed ·E. Karampli, Kyriakos Souliotis, N. P. Polyzos, John Kyriopoulos, Εkaterini Chatzaki	13
11	Both low and high serum progesterone levels on the day of human chorionic gonadotrophin (hCG) administration reduce live-birth rates during in-vitro fertilization (IVF/ICSI) 2013 ·Fertility and Sterility ·Samuel Santos‐Ribeiro, N. P. Polyzos, Herman Tournaye, Christophe Blockeel	1
12	Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study 2013 ·Human Reproduction ·N. P. Polyzos, Michel De Vos, Roberta Corona, Veerle Vloeberghs, Carolina Ortega‐Hrepich, Dominic Stoop, Herman Tournaye	31
13	Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger 2013 ·Reproductive BioMedicine Online ·(unknown), Herman Tournaye, Dominic Stoop, Inge Van Vaerenbergh, C. Bourgain, N. P. Polyzos, Patrick Haentjens, Christophe Blockeel	2
14	GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study 2012 ·Human Reproduction ·Evangelos Papanikolaou, George Pados, G. Grimbizis, (unknown), (unknown), N. P. Polyzos, Peter Humaidan, Herman Tournaye, Basil C. Tarlatzis	71
15	Treatment of poor ovarian responders with corifollitropin alpha followed by rFSH in an antagonist protocol. an observational pilot study 2012 ·Fertility and Sterility ·N. P. Polyzos, Michel De Vos, Peter Humaidan, Carolina Ortega‐Hrepich, Paul Devroey, Herman Tournaye	0
16	An OHSS-Free Clinic by segmentation of IVF treatment breakdown → 2011 ·Human Reproduction ·Paul Devroey, N. P. Polyzos, Christophe Blockeel	347
17	SELECTED ORAL COMMUNICATION SESSION, SESSION 50: ENDOCRINOLOGY, Tuesday 5 July 2011 17:00 - 18:00 2011 ·Human Reproduction ·Robert J. Norman, (unknown), (unknown), Laurie Wu, Michael A. Lane, (unknown), (unknown), Laura Sabatini, (unknown), Talha Al‐Shawaf, (unknown), Christophe Blockeel, N. P. Polyzos, Paul Devroey, (unknown), (unknown), (unknown), (unknown)	3
18	Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study 2010 ·Reproductive BioMedicine Online ·Evangelos Papanikolaou, C. Bourgain, H Fatemi, Willem Verpoest, N. P. Polyzos, (unknown), Efstratios M. Κolibianakis, Basil C. Tarlatzis, Paul Devroey, Herman Tournaye	12
19	Effect of Periodontal Disease Treatment During Pregnancy on Preterm Birth Incidence: A Meta-analysis of Randomized Trials 2010 ·Obstetric Anesthesia Digest ·N. P. Polyzos, (unknown), Davide Mauri, Spyridon Tzioras, (unknown), Ivan Cortinovis, Giovanni Casazza	30
20	Cancer screening practice and misplaced priorities in Greece 2008 ·Journal of Clinical Oncology ·(unknown), Antonis Valachis, Ivan Cortinovis, (unknown), N. P. Polyzos, Georgios Koukourakis, Dimitrios Tzachanis, (unknown), Gabriella Casazza, Davide Mauri	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact